Katz Liora S, Xu Shiliyang, Ge Kai, Scott Donald K, Gershengorn Marvin C
Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Endocrinology. 2018 Jan 1;159(1):557-569. doi: 10.1210/en.2017-00579.
Increasing brown adipose tissue (BAT) activity is regarded as a potential treatment of obese, hyperglycemic patients with metabolic syndrome. Triiodothyronine (T3) is known to stimulate BAT activity by increasing mitochondrial uncoupling protein 1 (Ucp1) gene transcription, leading to increased thermogenesis and decreased body weight. Here we report our studies on the effects of T3 and glucose in two mouse models and in mouse immortalized brown preadipocytes in culture. We identified carbohydrate response element binding protein (ChREBP) as a T3 target gene in BAT by RNA sequencing and studied its effects in brown adipocytes. We found that ChREBP was upregulated by T3 in BAT in both hyperglycemic mouse models. In brown preadipocytes, T3 and glucose synergistically and dose dependently upregulated Ucp1 messenger RNA 1000-fold compared with low glucose concentrations. Additionally, we observed increased ChREBP and Ucp1 protein 11.7- and 19.9-fold, respectively, along with concomitant induction of a hypermetabolic state. Moreover, downregulation of ChREBP inhibited T3 and glucose upregulation of Ucp1 100-fold, whereas overexpression of ChREBP upregulated Ucp1 5.2-fold. We conclude that T3 and glucose signaling pathways coordinately regulate the metabolic state of BAT and suggest that ChREBP is a target for therapeutic regulation of BAT activity.
增加棕色脂肪组织(BAT)的活性被视为治疗患有代谢综合征的肥胖、高血糖患者的一种潜在方法。已知三碘甲状腺原氨酸(T3)可通过增加线粒体解偶联蛋白1(Ucp1)基因转录来刺激BAT活性,从而导致产热增加和体重减轻。在此,我们报告了我们对T3和葡萄糖在两种小鼠模型以及培养的小鼠永生化棕色前脂肪细胞中的作用的研究。我们通过RNA测序确定碳水化合物反应元件结合蛋白(ChREBP)为BAT中的一个T3靶基因,并研究了其在棕色脂肪细胞中的作用。我们发现,在两种高血糖小鼠模型中,BAT中的ChREBP均被T3上调。在棕色前脂肪细胞中,与低葡萄糖浓度相比,T3和葡萄糖协同且剂量依赖性地上调Ucp1信使RNA达1000倍。此外,我们观察到ChREBP和Ucp1蛋白分别增加了11.7倍和19.9倍,同时伴随着高代谢状态的诱导。此外,ChREBP的下调抑制了T3和葡萄糖对Ucp1的上调达100倍,而ChREBP的过表达使Ucp1上调了5.2倍。我们得出结论,T3和葡萄糖信号通路协同调节BAT的代谢状态,并表明ChREBP是BAT活性治疗调节的一个靶点。